Caro et al.26 have detected the expression of CD68 and CD206 in 110 cases of pancreatic cancer by IHC, indicating that the positive proportion of M2 (CD68+CD206+) TAMs is 63%. This evidence concerns the gene CD68 and familial pancreatic carcinoma.